ORTHOCELL LIMITED — Director's Dealing 2016

Dec 1, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Orthocell Limited ABN 57 118 897 135

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Paul Anderson
Date of last notice	4/3/2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Mr Anderson is a trustee and beneficiary of the Elwing Superannuation Fund Nicole Telford – spouse
Date of change	28/11/2016
No. of securities held prior to change Paul Anderson and Nicole Telford Paul Anderson Nicole Telford Paul Anderson and Nicole Telford (Mr Anderson is a trustee and beneficiary of the Elwing Superannuation Fund)	6,403,335 Ordinary Shares 16 Ordinary Shares 750,000 Unlisted Options exercisable at $0.62 on or before 24 November 2017 250,000 Unlisted Options exercisable at $0.62 on or before 24 November 2017 570,399 Ordinary Shares 1,750,000 Unlisted options exercisable at $0.50 expiring 3 August 2017 13,692 Unlisted Warrants exercisable at $0.58 on or before 19 November 2020

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Unlisted Options
Number acquired	250,000 Unlisted Options
Number disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change Paul Anderson and Nicole Telford Paul Anderson Nicole Telford Paul Anderson and Nicole Telford (Mr Anderson is a trustee and beneficiary of the Elwing Superannuation Fund)	6,403,335 Ordinary Shares 16 Ordinary Shares 750,000 Unlisted Options exercisable at $0.62 on or before 24 November 2017 250,000 Unlisted Options exercisable at $0.62 on or before 24 November 2017 250,000 Unlisted options exercisable at $0.624 on or before 12 October 2019 570,399 Ordinary Shares 1,750,000 Unlisted options exercisable at $0.50 expiring 3 August 2017 13,692 Unlisted Warrants exercisable at $0.58 on or before 19 November 2020
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Options granted to Nicole Telford pursuant to the Orthocell Limited Employee Option Acquisition Plan and as approved by shareholders at the Annual General Meeting on 28 November 2016

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A

• See chapter 19 for defined terms.

Appendix

3Y

Page

2

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 Closed Period

Closed Period
Were the interests in the securities or contracts detailed above traded during a +closed period whereprior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3